Epilepsy-related prescription drugs and medical supplies cost sharing limitation provision

A bill for an act

relating to health insurance; limiting cost-sharing for epilepsy-related prescription

drugs and medical supplies; amending Minnesota Statutes 2024, section 62Q.481,

subdivision 2.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

Minnesota Statutes 2024, section 62Q.481, subdivision 2, is amended to read:

Subd. 2.

Definitions.

(a) For purposes of this section, the following definitions apply.

(b) "Chronic disease" means diabetes, asthma,
new text begin
epilepsy,
new text end
and allergies requiring the use

of epinephrine auto-injectors.

(c) "Cost-sharing" means co-payments and coinsurance.

(d) "Related medical supplies" means syringes, insulin pens, insulin pumps, test strips,

glucometers, continuous glucose monitors, epinephrine auto-injectors, asthma inhalers, and

other medical supply items necessary to effectively and appropriately treat a chronic disease

or administer a prescription drug prescribed to treat a chronic disease.

new text begin

EFFECTIVE DATE.

new text end

new text begin

This section is effective January 1, 2027, and applies to health

plans offered, issued, or renewed on or after that date.

new text end